Capital International Investors reports 5.4% Equifax (EFX) stake in amended 13G
Rhea-AI Filing Summary
Capital International Investors filed an amended Schedule 13G reporting beneficial ownership of 6,591,029 shares of Equifax common stock, representing 5.4% of the class. The filing is based on 122,394,037 shares believed outstanding as of the event date 12/31/2025.
The firm reports sole voting power over 6,530,805 shares and sole dispositive power over 6,591,029 shares, with no shared voting or dispositive power. It certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of Equifax.
Positive
- None.
Negative
- None.
FAQ
What stake in Equifax (EFX) does Capital International Investors report in this Schedule 13G/A?
How much voting power over Equifax (EFX) shares does Capital International Investors have?
What dispositive power over Equifax (EFX) shares is disclosed in the Schedule 13G/A?
Is Capital International Investors’ Equifax (EFX) position considered passive under this Schedule 13G/A?
What is the relevant event date for Capital International Investors’ Equifax (EFX) holdings?
Who signed the Schedule 13G/A reporting Capital International Investors’ Equifax (EFX) stake?